Point/counterpoint: randomized versus single-arm phase II clinical trials for patients with newly diagnosed glioblastoma.

ABSTRACT:

SUBMITTER: Grossman SA 

PROVIDER: S-EPMC5464324 | biostudies-literature | 2017 Apr

REPOSITORIES: biostudies-literature